Aroa Ferrer-Pinós

Ms. Aroa Ferrer-Pinós

CIMUS
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2024 in Science Advances
Verified
Journal Article
Open access
PAPaula Ayuso-García
Paula Ayuso-García
ASAlejandro Sánchez-Rueda
Alejandro Sánchez-Rueda
SVSergio Velasco-Avilés
Sergio Velasco-Avilés
MTMiguel Tamayo-Caro
Miguel Tamayo-Caro
Aroa Ferrer-PinósAroa Ferrer-Pinós
Aroa Ferrer-Pinós
AWAshwin Woodhoo
Ashwin Woodhoo
Myelination is essential for neuronal function and health. In peripheral nerves, >100 causative mutations have been identified that cause Charcot-Marie-Tooth disease, a disorder that can affect myelin sheaths. Among these, a number of mutations are related to essential targets of the posttranslational modification neddylation, although how these lead to myelin defects is unclear. Here, we demonstrate that inhibiting neddylation leads to a notable absence of peripheral myelin and axonal loss both in developing and regenerating mouse nerves. Our data indicate that neddylation exerts a global influence on the complex transcriptional and posttranscriptional program by simultaneously regulating the expression and function of multiple essential myelination signals, including the master transcription factor EGR2 and the negative regulators c-Jun and Sox2, and inducing global secondary changes in downstream pathways, including the mTOR and YAP/TAZ signaling pathways. This places neddylation as a critical regulator of myelination and delineates the potential pathogenic mechanisms involved in CMT mutations related to neddylation.

5 September 2021 in Fermentation
Verified
Journal Article
Open access
PDF file
Aroa Ferrer-PinósAroa Ferrer-Pinós
Aroa Ferrer-Pinós
Víctor Garrigós ContellesVíctor Garrigós Contelles
Víctor Garrigós Contelles
Emilia MatallanaEmilia Matallana
Emilia Matallana
Agustín ArandaAgustín Aranda
Agustín Aranda
Wine strains of Saccharomyces cerevisiae have to adapt their metabolism to the changing conditions during their biotechnological use, from the aerobic growth in sucrose-rich molasses for biomass propagation to the anaerobic fermentation of monosaccharides of grape juice during winemaking. Yeast have molecular mechanisms that favor the use of preferred carbon and nitrogen sources to achieve such adaptation. By using specific inhibitors, it was determined that commercial strains offer a wide variety of glucose repression profiles. Transcription factor Gln3 has been involved in glucose and nitrogen repression. Deletion of GLN3 in two commercial wine strains produced different mutant phenotypes and only one of them displayed higher glucose repression and was unable to grow using a respiratory carbon source. Therefore, the role of this transcription factor contributes to the variety of phenotypic behaviors seen in wine strains. This variability is also reflected in the impact of GLN3 deletion in fermentation, although the mutants are always more tolerant to inhibition of the nutrient signaling complex TORC1 by rapamycin, both in laboratory medium and in grape juice fermentation. Therefore, most aspects of nitrogen catabolite repression controlled by TORC1 are conserved in winemaking conditions.